… mortality. To better understand the effects of dapagliflozin on cause-specific mortality across … with symptomatic HF to treatment with dapagliflozin or placebo but enrolled adjacent …
U Karabulut, K Keskin, D Karabulut, E Yiğit… - Angiology, 2022 - journals.sagepub.com
… dapagliflozin have been shown to reduce rehospitalization and cardiac mortality in patients with heartfailure (… all-cause mortality of ARNI and dapagliflozin combination therapy against …
JJV McMurray, DL DeMets, SE Inzucchi… - … of heart failure, 2019 - Wiley Online Library
… Failure trial (DAPA-HF) is an international, multicentre, … with chronic heartfailure, evaluating the effect of dapagliflozin 10 … outcome of a worsening heartfailure event (hospitalization or …
JJV McMurray, DC Wheeler, BV Stefánsson, N Jongs… - Heart Failure, 2021 - jacc.org
… Dapagliflozin was also as effective at reducing mortality in patients with a history of HF as in those with no history of HF. Because patients with HF had a much higher risk of premature …
… the effect of dapagliflozin on patients with heartfailure, we … all-cause mortality, cardiovascular mortality, and heartfailure-… , and urgent heartfailure visits were observed with dapagliflozin …
… of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart … Dapagliflozin in patients with heartfailure and reduced ejection fraction. …
JJV McMurray, SD Solomon, SE Inzucchi… - … England Journal of …, 2019 - Mass Medical Soc
… Heart Association class II, III, or IV heartfailure and an ejection fraction of 40% or less to receive either dapagliflozin (at … The primary outcome was a composite of worsening heartfailure (…
… heartfailure and a left ventricular ejection fraction of more than 40% to receive dapagliflozin (… of several trials would be needed for robust evaluation of benefits with respect to mortality. …
… co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart … death or worsening heartfailure when dapagliflozin was initiated in patients with heartfailure with …